|
|
US 7,563,823 B2 |
|
| Modified release formulations of a bupropion salt |
| Werner Oberegger, Mississauga (Canada); Paul Maes, Toronto (Canada); Graham Jackson, Co. Kildare (Ireland); and Mohammad Ashty Saleh, Oakville (Canada) |
| Assigned to Biovail Laboratories International SRL., St. Michael (Barbados) |
| Filed on May 22, 2007, as Appl. No. 11/751,785. |
| Application 11/751785 is a continuation of application No. 11/475252, filed on Jun. 27, 2006, granted, now 7,241,805. |
| Claims priority of provisional application 60/693906, filed on Jun. 27, 2005. |
| Prior Publication US 2007/0269516 A1, Nov. 22, 2007 |
| This patent is subject to a terminal disclaimer. |
| Int. Cl. A61K 31/135 (2006.01)
|